Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Net Income: 2020-2025

Historic Net Income for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • LifeStance Health's Net Income rose 11807.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year increase of 8942.7%. This contributed to the annual value of -$58.4 million for FY2024, which is 6864.58% up from last year.
  • LifeStance Health's Net Income amounted to $1.1 million in Q3 2025, which was up 11807.96% from -$3.8 million recorded in Q2 2025.
  • LifeStance Health's 5-year Net Income high stood at $1.1 million for Q3 2025, and its period low was -$120.5 million during Q3 2021.
  • Over the past 5 years, LifeStance Health's median Net Income value was -$37.9 million (recorded in 2022), while the average stood at -$40.5 million.
  • As far as peak fluctuations go, LifeStance Health's Net Income tumbled by 355670.92% in 2021, and later soared by 11807.96% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's Net Income stood at -$108.0 million in 2021, then surged by 56.81% to -$46.7 million in 2022, then increased by 3.64% to -$45.0 million in 2023, then soared by 82.05% to -$8.1 million in 2024, then skyrocketed by 113.35% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, -$3.8 million for Q2 2025, and $709000.0 during Q1 2025.